Zhihua Wu

1.1k total citations
42 papers, 862 citations indexed

About

Zhihua Wu is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Zhihua Wu has authored 42 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Biomedical Engineering and 12 papers in Immunology. Recurrent topics in Zhihua Wu's work include Nanoplatforms for cancer theranostics (10 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Zhihua Wu is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Zhihua Wu collaborates with scholars based in China, United States and Australia. Zhihua Wu's co-authors include Yourong Duan, Liting Wang, Xupeng Yang, Ming Shen, Chuanrong Chen, Yi Dong, Dewei Zhao, Meng Zhao, Wen‐Ping Wang and Jiali Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

Zhihua Wu

40 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihua Wu China 15 395 374 173 150 140 42 862
Yangyang Du China 15 437 1.1× 462 1.2× 174 1.0× 178 1.2× 180 1.3× 24 920
Jia Tan China 15 518 1.3× 342 0.9× 125 0.7× 194 1.3× 292 2.1× 33 902
Chengyuan Dong China 11 360 0.9× 244 0.7× 256 1.5× 75 0.5× 122 0.9× 17 677
Kin Man Au United States 16 366 0.9× 238 0.6× 255 1.5× 151 1.0× 114 0.8× 24 858
Ping Cai China 12 299 0.8× 196 0.5× 172 1.0× 77 0.5× 227 1.6× 32 716
Kerong Chen China 18 428 1.1× 293 0.8× 206 1.2× 74 0.5× 147 1.1× 44 945
Rongqiang Zhuang China 18 385 1.0× 276 0.7× 142 0.8× 165 1.1× 182 1.3× 64 1.3k
Brian Wan-Chi Tse Australia 13 414 1.0× 210 0.6× 214 1.2× 105 0.7× 172 1.2× 24 822
Chaoming Mei China 16 360 0.9× 270 0.7× 149 0.9× 63 0.4× 222 1.6× 25 744
Isaac M. Adjei United States 15 328 0.8× 253 0.7× 188 1.1× 99 0.7× 161 1.1× 22 848

Countries citing papers authored by Zhihua Wu

Since Specialization
Citations

This map shows the geographic impact of Zhihua Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihua Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihua Wu more than expected).

Fields of papers citing papers by Zhihua Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihua Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihua Wu. The network helps show where Zhihua Wu may publish in the future.

Co-authorship network of co-authors of Zhihua Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihua Wu. A scholar is included among the top collaborators of Zhihua Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihua Wu. Zhihua Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Yi, Yi Duan, Bin Liu, et al.. (2024). Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism. Biomaterials. 309. 122609–122609. 10 indexed citations
2.
Gong, Ke, Zhihua Wu, Quan Wang, et al.. (2024). Nanosystem Delivers Senescence Activators and Immunomodulators to Combat Liver Cancer. Advanced Science. 11(20). e2308310–e2308310. 7 indexed citations
3.
4.
6.
Wu, Zhihua, Dewei Zhao, Xin Han, et al.. (2023). Deposition of hydrophilic Ti3C2Tx on a superhydrophobic ZnO nanorod array for improved surface-enhanced raman scattering performance. Journal of Nanobiotechnology. 21(1). 17–17. 13 indexed citations
7.
Qiu, Yijie, Zhihua Wu, Yanling Chen, et al.. (2023). Nano Ultrasound Contrast Agent for Synergistic Chemo‐photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis. Advanced Science. 10(21). e2300878–e2300878. 72 indexed citations
8.
Gong, Ke, Quan Wang, Zhihua Wu, et al.. (2023). Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma. Chinese Chemical Letters. 35(5). 108888–108888. 3 indexed citations
9.
Wang, Quan, Zhihua Wu, Ke Gong, et al.. (2023). Inhibition of atherosclerosis progression by modular micelles. Journal of Controlled Release. 354. 294–304. 19 indexed citations
10.
Wang, Quan, et al.. (2023). Dissolving microneedles-based programmed delivery system for enhanced chemo-immunotherapy of melanoma. Journal of Controlled Release. 360. 630–646. 18 indexed citations
12.
Yang, Xupeng, Meng Zhao, Zhihua Wu, et al.. (2022). Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy. ACS Nano. 16(2). 3417–3431. 91 indexed citations
13.
Guo, Chenyun, Hao Xu, Yu Zhou, et al.. (2022). Cefotetan-bound human RKIP involves in Ras/Raf1/MEK/ERK signaling pathway. Acta Biochimica et Biophysica Sinica. 54(12). 1917–1923. 3 indexed citations
14.
Xu, Ping, Xinxin Xu, Ruibo Zhao, et al.. (2021). Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer. European Journal of Medicinal Chemistry. 216. 113307–113307. 40 indexed citations
15.
Wu, Zhihua, Dewei Zhao, Yanhua Zhang, et al.. (2020). Facile synthesis of 3D hierarchical micro-/nanostructures in capillaries for efficient capture of circulating tumor cells. Journal of Colloid and Interface Science. 575. 108–118. 7 indexed citations
16.
Zhang, Yanhua, Yang Dong, Hao Fu, et al.. (2020). Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance. Biomaterials. 269. 120478–120478. 44 indexed citations
17.
Hu, Jian, Yi Dong, Li Ding, et al.. (2019). Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment. Signal Transduction and Targeted Therapy. 4(1). 28–28. 107 indexed citations
18.
Guo, Chenyun, et al.. (2018). Anti-leprosy drug Clofazimine binds to human Raf1 kinase inhibitory protein and enhances ERK phosphorylation. Acta Biochimica et Biophysica Sinica. 50(10). 1062–1067. 7 indexed citations
19.
Li, Wei, Zhijun Xu, Ruiqing Chu, et al.. (2015). Largely enhanced piezoelectric and luminescent properties of Er doped BST ceramics. RSC Advances. 5(111). 91903–91907. 9 indexed citations
20.
Liu, Changkun, et al.. (2009). Shape-Controlled Synthesis and Catalytic Behavior of Supported Platinum Nanoparticles. Synlett. 2009(4). 595–598. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026